Novozymes A/S (CPH:NSIS.B)
Denmark · Delayed Price · Currency is DKK 458.00
+9.00 (2.00%)
Oct 15, 2026, 4:59 PM CET
Novozymes Ratios and Metrics
Market cap in millions DKK. Fiscal year is January - December.
Millions DKK. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 213,389 | 189,890 | 189,431 | 102,816 | 97,304 | 148,795 | |
Market Cap Growth | 13.71% | 0.24% | 84.24% | 5.67% | -34.61% | 51.92% |
Enterprise Value | 234,021 | 210,998 | 202,332 | 109,201 | 103,220 | 153,514 |
Last Close Price | 449.00 | 400.78 | 394.49 | 355.70 | 326.64 | 492.13 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 44.37 | 43.57 | 83.06 | 33.98 | 26.47 | 47.30 |
Forward PE | 26.36 | 26.35 | 30.19 | 26.86 | 28.58 | 45.11 |
PS Ratio | 6.51 | 6.12 | 6.63 | 5.74 | 5.54 | 9.95 |
PB Ratio | 2.51 | 2.34 | 2.27 | 7.16 | 6.84 | 12.19 |
P/TBV Ratio | 790.43 | - | 22.05 | 10.88 | 10.65 | 21.87 |
P/FCF Ratio | 32.96 | 31.32 | 37.27 | 44.79 | 78.09 | 49.75 |
P/OCF Ratio | 21.23 | 20.82 | 24.91 | 24.76 | 24.29 | 36.63 |
PEG Ratio | 3.15 | 2.42 | 3.10 | 4.26 | 4.10 | 10.95 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 7.15 | 6.80 | 7.08 | 6.10 | 5.88 | 10.27 |
EV/EBITDA Ratio | 19.16 | 18.39 | 19.56 | 18.38 | 18.04 | 30.33 |
EV/EBIT Ratio | 30.87 | 29.38 | 32.19 | 23.98 | 23.04 | 39.42 |
EV/FCF Ratio | 36.21 | 34.81 | 39.80 | 47.57 | 82.84 | 51.33 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.28 | 0.28 | 0.16 | 0.54 | 0.49 | 0.52 |
Debt / EBITDA Ratio | 1.91 | 1.96 | 1.30 | 1.31 | 1.19 | 1.22 |
Debt / FCF Ratio | 3.62 | 3.70 | 2.64 | 3.39 | 5.58 | 2.11 |
Net Debt / Equity Ratio | 0.25 | 0.25 | 0.14 | 0.46 | 0.42 | 0.44 |
Net Debt / EBITDA Ratio | 1.72 | 1.78 | 1.09 | 1.12 | 1.03 | 1.06 |
Net Debt / FCF Ratio | 3.25 | 3.36 | 2.23 | 2.90 | 4.74 | 1.79 |
Asset Turnover | 0.26 | 0.26 | 0.40 | 0.64 | 0.67 | 0.66 |
Inventory Turnover | 2.29 | 2.48 | 3.05 | 2.20 | 2.34 | 2.36 |
Quick Ratio | 1.04 | 0.43 | 1.05 | 0.75 | 0.75 | 0.84 |
Current Ratio | 1.74 | 0.72 | 1.73 | 1.31 | 1.33 | 1.38 |
Return on Equity (ROE) | 5.77% | 5.30% | 4.67% | 21.27% | 27.89% | 26.82% |
Return on Assets (ROA) | 3.79% | 3.81% | 5.54% | 10.10% | 10.62% | 10.75% |
Return on Invested Capital (ROIC) | 5.68% | 5.75% | 7.97% | 17.18% | 19.24% | 19.23% |
Return on Capital Employed (ROCE) | 6.50% | 7.10% | 6.00% | 21.50% | 21.30% | 20.40% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 2.26% | 2.30% | 1.20% | 2.94% | 3.78% | 2.11% |
FCF Yield | 3.03% | 3.19% | 2.68% | 2.23% | 1.28% | 2.01% |
Dividend Yield | 1.42% | 1.62% | 1.57% | - | 1.84% | 1.12% |
Payout Ratio | 64.19% | 69.00% | 81.66% | 93.37% | 41.46% | 46.57% |
Buyback Yield / Dilution | -64.53% | -68.00% | -0.64% | 0.30% | 0.53% | 0.64% |
Total Shareholder Return | -63.08% | -66.38% | 0.92% | 0.30% | 2.37% | 1.75% |